Temocapril treatment ameliorates autoimmune myocarditis associated with enhanced cardiomyocyte thioredoxin expression

Molecular and Cellular Biochemistry

Volumn 248, Issue 1-2, 2003, Pages 185-192

  Yuan, Zuyi ^a   Kishimoto, Chiharu ^a   Shioji, Keisuke ^a   Nakamura, Hajime ^a   Yodoi, Junji ^a   Sasayama, Shigekake ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

ACE inhibitor; Myocarditis; Oxidative stress; Redox; Thioredoxin

Indexed keywords

CARBONYL DERIVATIVE; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL ENZYME; REGULATOR PROTEIN; TEMOCAPRIL; THIOREDOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL DAMAGE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; HEART MUSCLE CELL; IMMUNOHISTOCHEMISTRY; MYOCARDITIS; NEWBORN; NONHUMAN; OXIDATION REDUCTION STATE; PATHOPHYSIOLOGY; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; UPREGULATION; WESTERN BLOTTING;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; MYOCARDITIS; MYOCYTES, CARDIAC; OXIDATION-REDUCTION; OXYGEN; RATS; SUPEROXIDE DISMUTASE; SWINE; THIAZEPINES; THIOREDOXIN; TIME FACTORS; UP-REGULATION;

ANIMALIA;

EID: 0037627922     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024104906484     Document Type: Article

References (25)

1. Kodama M, Matsumoto Y, Fujiwara M et al.: A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57: 250-262, 1990
2. Hiraoka Y, Kishimoto C, Takada H et al.: Role of oxygen derived free radicals in the pathogenesis of coxsackievirus B3 myocarditis in mice. Cardiovasc Res 27: 957-961, 1993
3. Singh N, Dhalla AK, Seneviratne C, Singal PK: Oxidative stress and heart failure. Mol Cell Biochem 147: 77-81, 1995
4. Kaneko M, Masuda H, Suzuki H et al.: Modification of contractile proteins by oxygen free radicals in rat hearts. Mol Cell Biochem 125: 163-169, 1993
5. Aikawa R, Komuro I, Yamazaki T et al.: Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 1813-1821, 1997
6. Colucci WS: Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80: 15L-25L, 1997
7. Anversa P, Kajstura J, Olivetti G: Myocyte death in heart failure. Curr Opin Cardiol 11: 245-251, 1996
8. Tagaya Y, Maeda Y, Mitsui A et al.: ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: Possible involvement of dithiolreduction in the IL-2 receptor induction. EMBO J 8: 757-764, 1989
9. Shioji K, Kishimoto C, Nakamura H et al.: Upregulation of thioredoxin (TRX) expression in giant cell myocarditis in rats. FEBS Lett 472: 109-113, 2000
10. Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865, 1991
11. Kilgore KS, Homeister JW, Satoh PS, Lucchesi BR: Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury. Am J Physiol 266: H28-H35, 1994
12. Berkenboom G, Langer I, Carpentier Y, Grosfils K, Fontaine J: Ramipril prevents endothelial dysfunction induced by oxidized low-density lipoproteins. A bradykinin-dependent mechanism. Hypertension 30: 371-376, 1997
13. Rabbani R, Topol EJ: Strategies to achieve coronary arterial plaque stabilization. Cardiovasc Res 41: 402-417, 1999
14. de Cavanagh EMV, Fraga CG, Ferder L, Inserra F: Enalapril and captopril enhance antioxidant defenses in mouse tissue. Am J Physiol 272: R514-R518, 1997
15. Suzuki H, Matsumori A, Matoba Y et al.: Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury. J Clin Invest 91: 2727-2733, 1993
16. Araki M, Kanda T, Imai S et al.: Comparative effects of losartin, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus. J Cardiovasc Pharmacol 26: 61-65, 1995
17. Saito H, Nakamaru M, Rakugi H et al.: Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system. Clin Exp Pharmacol Physiol 17: 745-753, 1990
18. Oliver CN, Starke-Reed PE, Stadtman ER et al.: Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc Natl Acad Sci USA 87: 5144-5147, 1990
19. Nakamura H, Nakamura K, Yodoi J: Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997
20. Takagi Y, Mitsui A, Nishiyama A et al: Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci USA 96: 4131-4136, 1999
21. Spyrou G, Enmark E, Miranda-Vizuete A, Gustafsson J: Cloning and expression of a novel mammalian thioredoxin. J Biol Chem 272: 2936-2941, 1997
22. de Cavanagh EMV, Inserra F, Ferder L et al.: Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver. FEBS Lett 361: 22-24, 1995
23. de Cavanagh EMV, Inserra F, Ferder L, Fraga CG: Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am J Physiol 278: R572-R577, 2000
24. de Cavanagh EMV, Ferder L, Carrasquedo F et al.: Higher levels of antioxidant defenses in enalapril-treated versus non-enalapril-treated hemodialysis patients. Am J Kidney Dis 34: 445-455, 1999
25. Yamamoto M, Sata N, Tajima H et al.: Induction of human thioredoxin in cultured human retinal pigment epithelial cells through cyclic AMP-dependent pathway; involvement in the cytoprotective activity of prostaglandin E1. Exp Eye Res 65: 645-652, 1997